Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EXPEDITE: Misoprostol vs Dinoprostone for Labor Induction
NCT01127581Phase 3Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Sep 2010
- Primary completion
- Mar 2012
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Misopess in cervical ripening (CR) and labor induction (2 arms), sponsored by Ferring Pharmaceuticals. Primary endpoints: Time to Vaginal Delivery During the First Hospital Admission at 24 hours and Incidence of Cesarean Delivery During the First Hospital Admission at 24 hours. Started Sep 2010; status: completed.
02
Drugs
Misopess
03
Conditions
cervical ripening (CR)labor induction
Beyond the preview
Go deeper on NCT01127581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01127581.